Publications database

For more than 20 years, the European information network on drugs and drug addiction (Reitox), has been the cornerstone of the European drug monitoring and reporting system, to which it contributes by...

For more than 20 years, the EU drugs agency (EMCDDA) has demonstrated its ability to act as a catalyst for data collection and strategic analysis in a policy area that cuts across...

In this issue: Lisbon Addictions 2017 | New EMCDDA guide on responses | EMCDDA responds to increasing risks posed by new fentanils | IPA5 project draws to a close | Supporting global...

The EMCDDA receives stable funding under Commission budget line B3-441 of the general budget of the European Union. Each year, a preliminary draft budget is presented by the Centre's Director to the...

These are the EMCDDA's final annual accounts for the financial year 2016.

The General Report of Activities is an annual publication providing a detailed progress report of the EMCDDA’s activities over a 12-month period. It catalogues the Centre’s achievements in each area of its...

This strategy sets out an ambitious course of travel for the agency to 2025. It presents a vision to contribute to a healthier and more secure Europe, through better informed drug policy...